Skip to Main Content

Author Details

Kyoung-Mee Kim
Seoul National University College of Medicine
1991
668
62
PMIDPaper TitleJournal TitlePublished Year
36036680Clinical Characteristics and Therapeutic Outcomes of Pediatric Blepharokeratoconjunctivitis.Cornea2023
37654198Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.Cancer Med2023
37744267Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer.Oncol Res2023
37537533Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial.BMC Ophthalmol2023
37498877Intraocular lens power calculation in eyes with a shallow anterior chamber depth and normal axial length.PLoS One2023
37425307Severe ocular complications of SJS/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group.Front Med (Lausanne)2023
36950813Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer.J Pathol Transl Med2023
37081749TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.Cancer Med2023
37146064Etiology and outcome of penetrating keratoplasty in bullous keratopathy post-cataract surgery vs post-glaucoma surgery.PLoS One2023
37341658PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.J Pathol2023
37007114Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer.Front Oncol2023
36750994A Standardized Pathology Report for Gastric Cancer: 2nd Edition.J Gastric Cancer2023
36650632Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers.Cancer Med2023
36691829Lipid raft protein flotillin-1 is important for the interaction between SOS1 and H-Ras/K-Ras, leading to Ras activation.Int J Cancer2023
36834749Inflammation Confers Healing Advantage to Corneal Epithelium Following Subsequent Injury.Int J Mol Sci2023
36672418Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer.Cancers (Basel)2023
36455365Five-gene signature for the prediction of response to immune checkpoint inhibitors in patients with gastric and urothelial carcinomas.Pathol Res Pract2023
36700930SS-OCT-based ocular biometry in an adult Korean population with cataract.J Cataract Refract Surg2023
34120231Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer.Eur Radiol2022
35771810Clinical outcome of Descemet membrane endothelial keratoplasty (DMEK) with imported donor corneas in eyes of Asian patients; endothelium-in versus endothelium-out method.PLoS One2022
35440028Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome.BMC Ophthalmol2022
35405622Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers.Pathol Res Pract2022
35401527Proteomics Analysis of Aqueous Humor and Rejected Graft in Pig-to-Non-Human Primate Corneal Xenotransplantation.Front Immunol2022
35342406Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing.J Oncol2022
35574404Expression of CD274 mRNA Measured by qRT-PCR Correlates With PD-L1 Immunohistochemistry in Gastric and Urothelial Carcinoma.Front Oncol2022
35790315Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.J Immunother Cancer2022
36483096MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer.Pathol Oncol Res2022
36142641BAT26 Only Microsatellite Instability with High Tumor Mutation Burden-A Rare Entity Associated with PTEN Protein Loss and High PD-L1 Expression.Int J Mol Sci2022
36130695Multicenter prospective validation study for international chronic ocular graft-versus-host disease consensus diagnostic criteria.Ocul Surf2022
35989069Infectious Keratitis in Patients with Ocular Sjögren's Syndrome.Korean J Ophthalmol2022
36126450Gastric cancer with Epstein-Barr virus heterogeneity: Evaluation of the frequency, clinicopathologic features, and genomic profiles.Pathol Res Pract2022
36125657Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate.Mol Diagn Ther2022
36292044Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden.Diagnostics (Basel)2022
36017035Sutureless contact lens-type amniotic membrane for persistent epithelial defects after infectious keratitis.Int J Ophthalmol2022
36185166Gold Nanopyramid Arrays for Non-Invasive Surface-Enhanced Raman Spectroscopy-Based Gastric Cancer Detection via sEVs.ACS Appl Nano Mater2022
34949663High Frequency of Juxtamembrane Domain <i>ERBB2</i> Mutation in Gastric Cancer.Cancer Genomics Proteomics2022
34933901Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer.Cancer Discov2022
35327345Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches.Biomedicines2022
35299837Clinical Outcomes in Maximum Tolerated Medical Therapy in Penetrating Keratoplasty for Bullous Keratopathy.Front Med (Lausanne)2022
35135543Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers.BMC Med Genomics2022
34767183Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer.Clin Transl Oncol2022
34510272The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.J Cancer Res Clin Oncol2022
32755676Corneal xenotransplantation: Where are we standing?Prog Retin Eye Res2021
33494793Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.Genome Med2021
33717226Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors.Ther Adv Med Oncol2021
33654374Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker.Clin Ophthalmol2021
33767351Comparison of therapeutic effects between topical 8-oxo-2'-deoxyguanosine and corticosteroid in ocular alkali burn model.Sci Rep2021
33682969Invited commentary on "Deep Anterior lamellar keratoplasty with Cross-linked Acellular Porcine Corneal Stroma to Manage Fungal Keratitis".Xenotransplantation2021
33846173Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.Cancer Discov2021
33504920Large diameter scleral lens benefits for Asians with intractable ocular surface diseases: a prospective, single-arm clinical trial.Sci Rep2021
  • 1 - 50 of 668

Recommended Authors

Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Career Start Year 2008
Number of shared co-authors 2
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 1
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 0
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
The Fifth Affiliated Hospital, Sun Yat-sen University
Career Start Year 2002
Number of shared co-authors 0
Tokai University
Career Start Year 2002
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 1
Soonchunhyang University College of Medicine, Bucheon Hospital
Career Start Year 1999
Number of shared co-authors 6
Haeundae Paik Hospital, Inje University College of Medicine
Career Start Year 1999
Number of shared co-authors 2
Westchester Medical Center
Career Start Year 1998
Number of shared co-authors 3
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Chonbuk National University Hospital
Career Start Year 1998
Number of shared co-authors 5
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Samsung Medical Center, College of Medicine, The Sungkyunkwan University of Korea
Career Start Year 1997
Number of shared co-authors 2
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 2
Institute of Vision Research, Yonsei University College of Medicine
Career Start Year 1996
Number of shared co-authors 21
Department of Food Bioengineering, Jeju National University
Career Start Year 1996
Number of shared co-authors 2
College of Korean Medicine, Kyung Hee University
Career Start Year 1995
Number of shared co-authors 12
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Wonju Severance Christian Hospital
Career Start Year 1993
Number of shared co-authors 4
Xijing Hospital, The Fourth Military Medical University
Career Start Year 1992
Number of shared co-authors 1
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year 1992
Number of shared co-authors 2
The University of Tokyo
Career Start Year 1992
Number of shared co-authors 0
Inje University Haeundae Paik Hospital
Career Start Year 1992
Number of shared co-authors 0
Beijing Friendship Hospital, Capital Medical University
Career Start Year 1988
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 1973
Number of shared co-authors 3

Collaborators

Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 151
Busan Paik Hospital, Inje University
Co-authored papers 91
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 73
Research Institute, National Cancer Center
Co-authored papers 58
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 16
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 16
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 11
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 11
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Co-authored papers 11
Co-authored papers 10
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
Touro College of Osteopathic Medicine
Co-authored papers 4
Korea University, College of Medicine
Co-authored papers 4
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
National Center for Global Health and Medicine
Co-authored papers 4
Research Institute of Future Medicine, Samsung Medical Center
Co-authored papers 4
University of California San Diego Moores Cancer Center
Co-authored papers 4
Harvard Medical School
Co-authored papers 3
Co-authored papers 3
Ajou University
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
Sungkyunkwan University
Co-authored papers 3
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 3
Keimyung University School of Medicine
Co-authored papers 3
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers 3
Merck & Co., Inc.
Co-authored papers 3